📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

In vitro, classical complement activation differs by disease severity and between SARS-CoV-2 antigens (2021)

First Author: Lamerton R

Attributed to: Determining functional immunity after SARS-CoV-2 vaccination or natural infection in haemodialysis patients at high-risk of COVID-19 funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.11.22.21266681

Publication URI: http://dx.doi.org/10.1101/2021.11.22.21266681

Type: Preprint